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ABSTRACT 
 
Since Nordihydroguaiaretic acid (NDGA), a potent natural antioxidant, can produce oxidation in several cell kinds, 
mainly by superoxide anion production (O2

¯), the current study was designed to assess its capacity to produce or 
not this reactive oxygen species on Vero cell line, with the aim to establish whether this lignan behaves as a pro- or 
antioxidant. The O2

¯ production was determined by the Nitro Blue Tetrazolium reduction test. Results show that 
NDGA has a dual-face behavior on this eukaryotic cell model depending on the biological environment and its 
concentration. The NDGA behaved as a pro-oxidant when it was tested single, by means of an increase in O2

¯ 
production that was directly concentration-dependent. Mixed with an antioxidant (ascorbic acid) or a moderate 
oxidant (glucose), the NDGA behaved as pro-oxidant at low concentrations and antioxidant at high concentrations. 
 




Nordihydroguaiaretic acid (NDGA) is a natural 
phenolic compound, specifically defined as lignan, 
which has shown to have promising applications in 
the treatment of multiple diseases, including 
cardiovascular diseases, neurological disorders and 
cancers.
[1]
 This lignan is the main metabolite of 
several species of Larrea Cav. (Zygophyllaceae), 
particularly in Larrea tridentata (Sessé & Moc. ex 
DC.) Coville, the most studied species, which is 
popularly known as “creosote-bush”, “chaparral” or 
“greasewood” in United States and “gobernadora” or 
“hediondilla” in Mexico.
[2]
 Our working group 
established that NDGA is also the main component in 
bioactive extracts of Larrea divaricata Cav.,
[3]
 related 
specie with L. tridentata, but with habitat in arid 
regions of Argentina, in where it is popularly known 
as “jarilla”, and used in folk medicine as anti-
inflammatory and anti-rheumatic agent.
[4]
  
Among the proposed biological properties for the 
NDGA, its antioxidant effect has been one of the 
most widely studied. Nevertheless, over the years, 
others biological activities have been studied and this 
compound has gained popularity and interest due to 
its antineoplastic, antiviral and anti-inflammatory 
characteristics;
[2]
 even our research group has 
demonstrated that NDGA and the enriched-extracts 
in this lignan, obtained from L. divaricata, showed in 
vitro antiviral effect against Junin virus.
[3, 5]
 Thus, the 
potential medical applications of NDGA have 
attracted much interest, and numerous investigations 
have been published in the last few years, which 
include studies on molecular mechanisms as well as 
the pharmacokinetics and toxicity.
[2]
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It has been widely demonstrated that the antioxidant 
effect exhibited by the NDGA is due to its ability to 
trap free radicals or reactive oxygen species (ROS);
[6]
 
even some of its beneficial effects (anticancer; 
preventive agent of several toxic effects such as 
renal, liver and lung toxicity; anti-ulcerogenic and 
anti-inflammatory activities) have been attributed to 
its antioxidant property, especially its ability to 
prevent oxidative stress.
[1, 4,  6-9]
  
On the other hand, NDGA also has demonstrated pro-
oxidant effects in various cell types, being this action 
responsible both for its toxicity and for antitumor 
activity.
[10, 11]
 In addition, Sahu et al.
[12]
 established 
that this polyphenol compound has the potential to 
act both as a pro- and antioxidant depending on its 
concentration and biological environment. 
An interesting biological environment to study the 
NDGA behavior (pro- or antioxidant) that has not 
been previously used for this purpose, is a 
mammalian cellular eukaryotic line such as the Vero 
cells; which can be used in different studies, 
primarily to evaluate the in vitro antiviral effect of a 
compound, since they are susceptible to infection by 
different kind of viruses. 
Therefore, the aim of this study was to assess 
whether the NDGA acts as O2

¯ generator (pro-
oxidant) or as scavenger (antioxidant) of this reactive 
species (generated by an oxidizing agent) on Vero 
cell line; and how this behavior can be influenced by 
the NDGA concentration and the biological 
environment when it is present an antioxidant or an 
oxidizing agent. 
 
MATERIALS AND METHODS 
 
Samples and reagents: Standard NDGA was 
obtained from L. divaricata by Dr. C.E. Tonn 
(INTEQUI-CONICET, Argentina) and identified by 
its spectroscopic properties (MS and UV-V), in 
agreement with those found in the literature.
[13]
 
Ascorbic acid (AA) and glucose (Glu) were 
purchased in Merck. 
The following reagents were used: Eagle’s minimum 
essential medium (EMEM, Gibco), Fetal calf serum 
(FCS, Natocor), L-glutamine (Calbiochem), 
gentamicin (Klonal), dimethylsufoxide (DMSO, 
Tetrahedron), Neutral Red (NR, Gibco), Phosphate 
buffer saline (PBS), Nitro Blue Tetrazolium (NBT, 
Sigma). 
 
Cells: African green monkey kidney cells 
(Cercopithecus aethiops, Vero 76 ATCC CRL-587) 
were used. They were grown and kept alive under 
humid atmosphere with 5 % CO2 at 37 °C. EMEM 
supplemented with 10 % FCS, 1 % L-glutamine, and 
gentamicin (50 μg/mL) was used as growth medium 
(GM), whereas EMEM plus 2 % FCS containing the 
same formulation as described above and 1 % DMSO 
was used as maintenance medium (MM). 
 
In vitro cytotoxicity Test 
Samples for cytotoxicity assays: A stock solution of 
NDGA (10 mg/mL in DMSO) was used to achieve 
15 consecutive dilutions with MM, in a range of 1-55 
μg/mL. In the case of AA (100 mg/mL in MM), 15 
dilutions were prepared between 5 and 2000 µg/mL 
in MM. From a Glu solution (2.5 M in PBS) 15 
dilutions were performed between 500 and 10 mM in 
MM (this medium already has a low Glu 
concentration, 5 mM). 
 
Cytopathic effect: By means of inverted optical 
microscopy, the action of NDGA and ascorbic acid 
on the morphology of Vero cells were observed.
[14]
 
Each dilution was inoculated in duplicate on a 
confluent cell monolayer (2.5 ± 0.6 x 10
5
 cells/mL, 
48 h incubation), grown in a 48 well-plaque. Cell 
controls (CC) that contain only MM were included (n 
= 2). The cells were incubated at 37 °C during 72 h, 
and the development of cellular alterations such as 
rounding, membrane retraction, cell detachment and 




Cell viability assay: Cellular viability (CV) vs. 
concentrations of each compound was measured by 
means of the uptake NR assay in a 96 well-plaque. 
The same 15 dilutions used before was inoculated in 
triplicate on a confluent monolayer of cells (1.0 ± 0.6 
x 10
5
 cells/mL), according to the methodology 
described by Borenfreund & Puerner.
[14]
 The 
absorbance of the NR extracted after 48 h of 
incubation at 37 °C was measured at 540 nm on a 
microplate reader (BioTekELx800). The percentage 
of CV (CV%) was calculated by comparison with CC 
(100 % viability, without sample, n = 3). The 
concentration of the compound that reduces the 
viable cells to 50 % (CC50) was determined by 
regression (R
2
 > 0.9) from the plot of CV% vs. 
compound concentrations. Maximum Non-Cytotoxic 
Concentration (MNCC) was defined as the maximum 
concentration of sample that exhibits more than 90 % 
viable cells and exerts no cytotoxic effect detected by 
microscopic monitoring.
[16]
 In addition, a subtoxic 
concentration (SubTC) was determined as the 
concentration that causes 10 - 20% cellular death
[17]
 
and produces slight morphologic changes observed 
by microscopy (less than 20% of swollen and 
rounded cells, with cytoplasmic inclusions, slight 
vacuolization, and the nuclear membrane remaining 
intact). 
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Determination of O2
¯
 production: To evaluate the 
intracellular generation of O2
¯
, the NBT bioassay 
adapted to a confluent monolayer of cells attached to 
a multiwell-plate was used.
[18]
 In this test, the yellow-
colored NBT is absorbed by cells and reduced to 
water-insoluble Blue Formazan by the action of O2
¯ 
intracellular, in the presence and absence (basal 
situation) of the tested compound. 
Preformed Vero cell monolayers (1.0 ± 0.6 x 10
5
 
cells/mL, 48 h) in 24-well plate were washed 4 times 
with PBS (250 µL per well and per time) to remove 
any remaining GM. Dilutions of all compounds to 
assess were added, which were prepared in PBS from 
corresponding stock solutions. Thus, different 
concentrations of NDGA and AA, in a range 
covering the CC50, were inoculated in duplicate. By 
contrast, the Glu was only tested at its SubTC in 
duplicate, which was determined by the in vitro 
cytotoxicity assay (Table 1). Then, NBT (0.1 mg/mL 
in PBS with 1% DMSO) was added. Wells with cells 
in PBS (1% DMSO) without sample were included as 
control cells (CC, n = 2) to determine the basal O2
¯
 
production. The multiwell-plate was incubated during 
1h at 37 ºC under CO2 atmosphere, following the 
methodology described by Choi et al.
[19]
 The 
absorbance of intracellular Blue Formazan was 
measured on a microplate reader (BioTek ELx800) at 
630 nm. The O2
¯
 production in the presence of 
oxidant or antioxidant compounds was expressed as 
an increase or decrease in absorbance respectively, 
compared to the basal situation (CC). The increase in 
the percentage of O2
¯
 production vs. concentrations 
of compound was plotted. 
 
Data analysis: MNCC, SubTC and CC50 values were 
graphically obtained from the dose-response plots, 
which have a non-lineal regression analysis 
(Sigmoidal Origin, R
2
 > 0.9). The values were 
expressed as (mean ± standard error) from three 
independent experiments. Thus, for each 
concentration, 6 replicates were carried out to 
determine cytopathic effect, 9 replicates to quantify 
cell viability, 6 replicates to evaluate the intracellular 
O2
¯
 production. The t-test (Origin) was used to 
assess the degree of statistical difference of MNCC, 
CC50 and the SubTC values; differences between 
means were considered significant at p < 0.05. 
 
Table 1: Cytotoxic concentration to 50% cells (CC50), subtoxic concentration (SubTC) and Maximum Non-










15.4 ± 0.4 
9.9 ± 0.4 6.9 ± 0.3. 
Ascorbic acid 
852.2 ± 87.97 
544.6 ± 50.1 306.7 ± 29.5 
Glucose 
nd 
(4.8 ± 0.1) x 10
4
 (3.19 ± 0.06) x 10
4
 
nd: not determined because it was not toxic to 50% of the cells. 
 
RESULTS AND DISCUSSION 
 
The CC50, SubTC and a MNCC of NDGA (Table 1) 
were determined by extrapolation from the plot of 
CV% vs. NDGA concentrations (Fig. 1A). Thus, a 
concentration range where cellular viability is equal 
or higher than 90% was established from 1.0 µg/mL 
up to the MNCC (6.9 µg/mL). 
Figure 2A shows the morphological changes of a 
Vero cell monolayer treated with NDGA at the CC50. 
There are clearly signs of lack of cellular viability, 
since cells showed retraction with very little dye 
inside, compared to those that were not exposed to 
the compound (Fig. 2B), in where cellular lysosomes 
containing dye can be appreciated as a sign of 
viability. 
 
The data obtained in the NBT assay are shown in Fig. 
1B as the percentage increase in the production of 
O2
¯
 respect to basal situation. After 1h incubation, 
NDGA increased the generation of O2
¯
 in direct way 
to its concentration, and thus the oxidative stress over 
the cell monolayer was demonstrated. The maximum 
increment of O2
•¯
 (194.90 ± 0.02 %) was noted at the 
CC50, whereas this production lowered at SubTC 
(103.00 ± 0.03 %) and at the MNCC (43.70 ± 0.04 
%) (Data extrapolated from the plot, Fig. 1B). 
Although the values of O2
¯
 production at the MNCC 
and SubTC were elevated respect to CC, it can be 
inferred that this increase was not enough to cause 
significant damages on the cells during 1 h 
incubation, since no apparent morphological 
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alterations were observed by inverted optical 
microscopy (the cells were examined every 15 min 
during incubation). This agrees with results of a 
previous work of our research group,
[18]
 in where we 
also observed that an increase in the O2

¯ production 
is not necessarily associated with the generation of 
cytopathic effect. Not forget that against an increase 
of ROS, the total antioxidant cell system is activated, 
in which enzymatic and non-enzymatic components 
are involved to counteract the effect of these reactive 
species.
[20]
 However, it should be noted that NDGA 
began to be cytotoxic from concentrations greater 
than 10 µg/mL (near the SubTC), by means of a 
decrease in cellular viability, which would seem to be 
directly related with a rise in the O2

¯ production, 
probably because of an imbalance between the 
production of oxidant species and the triggering of 
antioxidant defenses.
[20]
 This behavior is describing a 
pro-oxidant capacity of the NDGA, which has 
already been observed by other researchers but in 
other cell models;
[10, 11, 21]
 even Sahua et al.
[12]
 have 
shown that this pro-oxidant action produces an 
increase in oxidative stress, oxidative cell injury and 
cytotoxicity. Therefore, we decided to assess the 
behavior of a recognized antioxidant compound such 
as Ascorbic acid (AA), in order to compare its 
performance in this biological system with the effect 
exhibited by the NDGA, thus the AA was used as a 
positive control. 
Comparison of cytotoxicity with O2

¯ production 
generated by the NDGA (Fig.1A and B) and AA 
(Fig. 3), shows that both compounds act as pro-
oxidants in this biological system, in direct 
proportion to concentration; which in turn leads to an 
increase in cytotoxicity. Thus, this result confirms the 
findings found by other researchers about the double-
faced character of AA, since it exhibits a pro-oxidant 
activity arising from its usual antioxidant property 
that generates reactive free radicals, which induce 
cytotoxic effects.
[22-25]
 The pro-oxidant activity of AA 
is a dose-dependent effect and is a result of the 
Fenton mechanism.
[24]
 Ascorbate is an excellent 
reducing agent (it donates electrons), so it is a 
powerful antioxidant; however, during this process it 
is easily auto-oxidized. There are enzymes 
(reductases) in the biological medium that reduce the 
ascorbate to recover its antioxidant effect.
[23]
 
However, the ascorbate can reduce the oxygen to 
generate ROS at a very low reaction rate,
[26]
 but 





 Thus, in the presence of catalytic metals, 
ascorbate also has pro-oxidant effects, where the 
redox-active metal is reduced by ascorbate and then 
in turn reacts with oxygen, producing superoxide that 
subsequently dismutes to produce H2O2.
[23]
 The pro-
oxidant toxicity of NDGA may be related to its 
ability to undergo autoxidation, such as other 
phenolic compounds (flavonoids), to produce 
superoxide anions.
[27]
 This is supported by the results 
of Bilinski & Krol,
[28]
 who demonstrated that the 
ortho-quinone species generated by autoxidation of 
NDGA, produces lipid peroxidation, suggesting an 
increase in oxidative stress.  
In addition, we have observed that it is necessary a 
greater concentration of AA (CC50) than NDGA to 
produce a similar cytopathic effect (Table 1), hence 
the AA is less cytotoxic. However, the AA exhibited 
a higher production of O2

¯ than the NDGA at their 
CC50. Therefore, it can be deduced that other 
mechanisms are involved in the cytopathic effect of 
NDGA besides oxidative stress. Based on this 
observation, we only compared the O2
¯
 production 
between NDGA and AA without considering the 
cytopathic effect. 
Bearing in mind that NDGA may have a dual 
biological behavior, as pro- or antioxidant, and this 
effect is directly dependent on its concentration and 
biological environment, we evaluated the behavior of 
NDGA under two experimental conditions at 
different concentrations: 1) along with another 
antioxidant compound (AA), and 2) together with an 
oxidizing compound as Glucose (Glu).
[29] 
To assess the effect of NDGA in the presence of AA, 
several experiments were performed, in where the 
O2
¯
 production was only evaluated, since this is the 
first reactive oxygen species that occurs and 




O2), according to the Fenton reaction.
[30]
 
Each compound was tested at its SubTC (Table 1), 
which was estimated from cytotoxicity curves (Fig. 
1A y 3A). This concentration was chosen because it 
does not produce a marked toxic effect on cells, and 
ensures a constant O2

¯ production (Fig. 1B y 3B).  
Figure 4 shows the growth of O2
¯
, expressed as 
increase in Abs of reduced-NBT by this ROS. It can 
be observed that the O2
¯
 generated by the NDGA 
and AA (positive control) was higher than that 
produced by the mixture of both compounds (1:1), 
but this decline when both compounds are mixed was 
very slight; so the action of both compounds mixed in 
same proportion (1:1) was not enough to reach the 
basal production (cells alone). 
Then, the O2
¯
 produced by the combination of both 
compounds was studied, keeping constant the 
concentration of a compound and varying the 
concentration of the other (Fig. 5A y 5B). When 
NDGA was tested at a constant concentration 
(SubTC) combined with varying concentrations of 
AA (SubTC, 2xSubTC and 3xSubTC) (Fig 5A), it is 
observed that the mixture of both compounds 
behaves similarly to AA. A sum of the effects of both 
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compounds was not observed, but rather the effect of 
AA had primacy over the NDGA, since the O2
¯
 
production by this lignan was insignificant compared 
to AA (Fig 1B y 3B). 
When the AA was tested at a constant concentration 
(SubTC) combined with varying concentrations of 
NDGA (1/2SubTC, SubTC, 1,5xSubTC and 
2xSubTC) (Fig 5B), a slight increase in the O2

¯ 
production was observed with increasing 
concentrations of NDGA, reaching a peak production 
at 10 µg/mL (SubTC). Higher concentrations of 
NDGA in the mix produced a significant decrease in 
the O2

¯ generation, without achieving the total 
reduction of this radical. Therefore, the NDGA in the 
presence of a constant concentration of AA would 
have a reducing effect on the generation of O2

¯, 
which is concentration-dependent. It is difficult to 
give an explanation to the combined action of two 
antioxidants because each one has an affinity for one 
or more specific free radical, can act in different 
processes of the oxidative sequence and have more 
than one mechanism of action.
[31]
  
In Figure 6, the O2

¯ production generated by 
different concentrations of NDGA in the presence 
and absence of an oxidant is assessed. For that, 
glucose (Glu) was used at its SubTC (Table 1), 
determined by the corresponding cytotoxicity curve 
(Data not shown), since this concentration ensures a 
constant production of O2

¯ and the cells remain 
viable. In the presence of a constant concentration of 
Glu (SubTC), NDGA showed a dual action. 
Concentrations lower than 10 µg/mL of NDGA 
(inflection point) slightly increased the O2

¯ 
production as compared with the single effect 
produced by Glu. In contrast, concentrations greater 
than 10 µg/mL of NDGA in the mix triggered a 
reduction in O2

¯ production, compared with the 
generation of O2

¯ caused individually by Glu and 
NDGA. It can be observed that a total inhibition of 
O2

¯ production is achieved when the concentration 
of NDGA in the mixture are greater than 15 µg/mL. 
Experiments, where Glu concentrations change in 
presence of a fixed concentration of NDGA, were not 
performed because it was not our interest to study the 
behavior of glucose. 
 
                                        
                                        
                                        
                                        
                                        
                                        























                                        
                                        
                                        
                                        
                                        
                                        
                                        



























Figure 1: NDGA cytotoxicity (A) and Percentages of O2
¯
 production vs. NDGA concentrations (B) 
Error bars represent the standard deviation obtained from three independent experiments 
 
 
Figure 2: Morphological changes produced by NDGA at the CC50 on a Vero cells monolayer (A) compared to 
a monolayer without treatment (B). RN uptake assay. Photographs were captured with an inverted optical 
microscope (40X). 
A B 
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Figure 3: Ascorbic acid (AA) cytotoxicity (A) and Percentages of O2
¯
production vs. AA concentrations (B) 





production by NDGA, ascorbic acid (AA) and a mixture of both compounds (1:1) at its subtoxic 
concentrations: NDGA (9.9 ± 0.4 µg/mL) and AA (544.6 ± 50.1µg/mL). 
Error bars represent the standard deviation obtained from three independent experiments 
* p>0,01, NDGA vs AA (α = 0,05). **p<0,01, NDGA + AA vs NDGA; NDGA + AA vs. AA (α = 0,05). 
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 AA at varying concentrations
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 NDGA at varying concentrations
 AA at SubTC




: 0,99915 (A)                                             R
2
: 0,99836 (B)  
Figure 5: O2
¯
 production by a mixing of NDGA with another antioxidant (Ascorbic acid, AA), keeping 
constant the concentration of one compound (SubTC) and varying the concentration of the other. A) NDGA 
at constant concentration with varying concentrations of AA. B) AA at constant concentration with varying 
concentrations of NDGA. 
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¯ production by NDGA and mixed with a compound able to produce oxidative stress (Glucose, 
Gluc). 




Our results show that NDGA has a dual-face 
behavior (pro- or antioxidant) on Vero cells. When 
the NDGA was tested single on the cellular line, it 
increased the O2

¯ production (pro-oxidant) in a 
directly concentration-dependent manner, which also 
caused an increment in the cytotoxic effect, probably 
due to a stimulation of the oxidative stress. This same 
behavior was observed for the AA, another 
antioxidant used as positive control in this study. This 
dual-face effect of NDGA and AA would be related 
to its polyphenol nature, since those having a phenol 
ring, like these compounds, turn out pro-oxidants.
[27]
 
Moreover, it should be noted that in this cellular 
model (Vero cells), the AA (recognized antioxidant) 
behaves as a strong pro-oxidant, since its O2

¯ 
production was greater than that produced by the 
NDGA (Figs. 3B vs 1B). Therefore, our results are 
further evidence that the NDGA and AA can act as 
prooxidants and thus generate oxidative stress. 
On the other hand, in presence of an antioxidant 
(AA) or a moderate oxidant (Glu), NDGA exhibited a 
similar behavior that was pro- or antioxidant 
depending on the concentration. That is, low 
concentrations of NDGA (≤ 9.9 µg/mL) increased 
slightly the O2

¯ production (pro-oxidant). However, 
concentrations exceeding 9.9 µg/mL decreased the 
generation of this ROS (antioxidant), achieving the 
basal situation only when in the biological 
environment was present a moderate oxidant such as 
Glu. 
Thus, the NDGA is able to behave as a pro- or anti-
oxidant, according to the environment in which it is 
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